Discover
RNTX
Rein Therapeutics Inc.
0.98
1 x 0.95
1 x 0.99
bid
ask
-
0.06
5.96%
1 @ 04:00 PM
0.95 -0.02 (2.45%)
| Ytd | -15.69% | |
| 1y | -32.55% |
0.95
day range
1.03
0.86
52 week range
2.18
| Open | 1.01 | Prev Close | 1.04 | Low | 0.95 | High | 1.03 | Mkt Cap | 83.66M |
| Vol | 845.06K | Avg Vol | 788.18K | EPS | -1.90 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.12 | 200-d Avg | 1.27 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 5.23M | ||
| Research and Development Expense | 3.07M | ||
| Selling, General and Administrative Expense | 2.16M | ||
| Operating Income | -5.23M | ||
| Net Income | -5.84M | ||
| Net Income Common Stock | -5.84M | ||
| Net Income Common Stock (USD) | -5.84M | ||
| Consolidated Income | -5.84M | ||
| Earnings per Basic Share | -0.19 | ||
| Earnings per Basic Share (USD) | -0.19 | ||
| Earnings per Diluted Share | -0.19 | ||
| Earning Before Interest & Taxes (EBIT) | -5.84M | ||
| Earning Before Interest & Taxes (USD) | -5.84M | ||
| Weighted Average Shares | 30.35M | ||
| Weighted Average Shares Diluted | 30.35M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.45M | ||
| Cash and Equivalents (USD) | 4.45M | ||
| Current Assets | 5.45M | ||
| Total Assets | 26.29M | ||
| Debt Current | 4.92M | ||
| Total Debt | 4.92M | ||
| Current Liabilities | 13.64M | ||
| Total Liabilities | 14.70M | ||
| Accumulated Retained Earnings (Deficit) | -407.11M | ||
| Accumulated Other Comprehensive Income | -62.00K | ||
| Shareholders Equity | 11.59M | ||
| Shareholders Equity (USD) | 11.59M | ||
| Assets Non-Current | 20.84M | ||
| Total Debt (USD) | 4.92M | ||
| Goodwill and Intangible Assets | 19.83M | ||
| Liabilities Non-Current | 1.06M | ||
| Trade and Non-Trade Payables | 6.26M | ||
| Tax Liabilities | 1.06M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 4.65M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.23M | ||
| Issuance (Purchase) of Equity Shares | 354.00K | ||
| Issuance (Repayment) of Debt Securities | 4.30M | ||
| Net Cash Flow from Operations | -3.42M | ||
| Share Based Compensation | 156.00K | ||